Part,  Chapter, Paragraph

 1   II,     5.  2.  6|             Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino
 2   II,     5.  4.  8|                 S, Cederholm J, Nilsson PM, Eliasson B; Steering Committee
 3   II,     5.  4.  8|                 45(7): S5-12.~ ~Jonsson PM (2000), Marke LA, Nystrom
 4   II,     5.  5.  3|        Epilepsia 19:343-350.~Callenbach PM, Westendorp RG, Geertz AT,
 5   II,     5.  5.  3|            Neurology 26:20-22.~Rothwell PM, Charlton D (1998): High
 6   II,     5.  5.  3|                 Sullivan DJ, Williamson PM (1999): The sydney multicentre
 7   II,     5.  6.  6|                 Soc Med 26:34-43~Brooks PM (1997): MJA Practice Essentials -
 8   II,     5.  9.  4|                 chemical composition of PM on release of cytokines
 9   II,     5.  9.  4|                 the potential hazard of PM. The present study also
10   II,     5.  9.  4|                chemical constituents of PM based on the overall response
11   II,     5.  9.  4|               that biological effect of PM can be linked to one or
12   II,     5.  9.  4|                be linked to one or more PM emission sources and that
13   II,     5.  9.  4|       Steerenberg PA 2006)~Fine ambient PM exerted significantly greater
14   II,     5.  9.  4|               per unit mass than coarse PM. No significant differences
15   II,     5.  9.  4|                 of specific elements of PM such as vanadium (V), nickel (
16   II,     5.  9.  4|                 fine compared to coarse PM fractions. However, differences
17   II,     5.  9.  4|               these elements among fine PM fractions did not reflect
18   II,     5.  9.  4|              number) to Ova and ambient PM in combination were significantly
19   II,     5.  9.  4|     significantly higher than to Ova or PM alone. Still, the PLN assay
20   II,     5.  9.  4|                conclusion, fine ambient PM fractions were consistently
21   II,     5.  9.  4|              fine and ultrafine ambient PM as the most important fractions
22   II,     5.  9.  4|                 the particulate matter (PM) it contains. In collaboration
23   II,     5.  9.  4|          sampling and analysing ambient PM and freshly generated diesel
24   II,     5.  9.  4|              diesel and gasoline engine PM. They are screening the
25   II,     5.  9.  4| physico-chemical characteristics of the PM to the results of the various
26   II,     9.  1.  1|                2004(24):14-22.~Olausson PM, Cnattingius S, Goldenberg
27   II,     9.  3.  2|                110(1):72-80.~ ~Olausson PM, Cnattingius S, Goldenberg
28  III,    10.  1    |                   Cancer~air pollution (PM), mainly PM2.5 or less~smoking
29  III,    10.  1    |                  carbon monoxide, ozon, PM)~smoking and ETS~carbon
30  III,    10.  1.  3|                BH, Williams DM, Dubbert PM, Sallis JF, King AC, Yancey
31  III,    10.  2.  1|           Dorosty AR, Reilly JJ, Emmett PM, for the Child health information
32  III,    10.  2.  4|                 RP, Rollinson S, Bracci PM, Cerhan JR, Whitby D, Moore
33  III,    10.  3.  2|                   Cancer~air pollution (PM), mainly PM2.5 or less~smoking
34  III,    10.  3.  2|                  carbon monoxide, ozon, PM)~smoking and ETS~carbon
35  III,    10.  4.  1|               Nitrogen Dioxide~O3~Ozone~PM~Particulate Matter~SCALE~
36  III,    10.  4.  1|                 are particulate matter (PM), especially fine and ultra-fine
37  III,    10.  4.  1|                 EU citizen. Exposure to PM is also linked to an increased
38  III,    10.  4.  1|                the health impact due to PM between 2000 and 2020, which
39  III,    10.  4.  1|               In addition to particles (PM), many studies indicate
40  III,    10.  4.  1|          Chronic exposure:~o Mortality (PM) – the dominant effect~o
41  III,    10.  4.  1|              Development of bronchitis (PM)~ ~· Acute exposure (daily
42  III,    10.  4.  1|             admissions~ ~· Respiratory (PM,O3); Cardiovascular (PM)~
43  III,    10.  4.  1|                 PM,O3); Cardiovascular (PM)~o Days of restricted activity;
44  III,    10.  4.  1|                activity; days off work (PM,O3 )~o Days with symptoms (
45  III,    10.  4.  1|                   o Days with symptoms (PM, O3 )~ ~ In people with
46  III,    10.  5.  1|            Reduction potential of urban PM 25 mortality risk using
47  III,    10.  5.  1|               Polychlorinated Biphenyls~PM~Particulate Matter~THE PEP~